The use of cost-effectiveness analysis for pediatric immunization in developing countries.

Area of Science:

• Health Economics
• Public Health Policy
• Pediatric Immunization

Background:

• Developing countries face challenges allocating resources for expensive new vaccines to reduce child mortality.
• Cost-effectiveness analysis (CEA) is crucial for resource allocation but underutilized in developing nations.
• International donor funding significantly impacts immunization resource availability and policy decisions.

Purpose of the Study:

• To enhance the relevance of CEA for immunization policymaking in developing countries.
• To identify limitations in applying CEA within developing country contexts.
• To assess the influence of donor funding on CEA estimations for immunization programs.

Main Methods:

• Comprehensive literature search of indexed and gray literature using formal protocols.
• Systematic thematic analysis of CEA applications in industrialized and developing countries.
• Focus on pediatric immunization, methodological challenges, and contextual factors in developing nations.

Main Results:

• Divergent use of CEA methodologies between industrialized and developing countries, with unique approaches like DALYs in developing nations.
• Pediatric CEAs are often limited by evaluation scarcity and methodological oversights (e.g., discounting, preference characterization), potentially undervaluing interventions.
• Inadequate consideration of donor funding impacts (e.g., GAVI) on measurement uncertainty and opportunity cost hinders high-quality evidence generation for child health.

Conclusions:

• Improving CEA for pediatric interventions and donor funding is essential for better health policies.
• Addressing methodological limitations in CEA can lead to more accurate valuation of child health programs.
• Enhanced CEA practices can optimize resource allocation for valuable, cost-effective immunization programs benefiting children in developing countries.